Randomized Phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) with MGMT promoter hypermethylation
- Citation:
- J Clin Oncol vol 40 (16_suppl) 2001-2001
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 4256
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA180868 (NRG); U10CA180888
- Corr. Author:
- Authors:
- Jann N. Sarkaria Karla V. Ballman Sani H. Kizilbash Erik P. Sulman Caterina Giannini Bret Friday Jesse G. Dixon Brian F. Kabat Nadia Laack Leland Hu Ben Ellingson S. Keith Anderson Evanthia Galanis
- Networks:
- ESSENTIA, LAPS-MN026, LAPS-TX035
- Study
- Alliance-A071102
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2/3
- Keywords: